Executive record
Dana Pizzuti, M.D.
Chief Medical and Development Officer at Crinetics Pharmaceuticals, Inc.
More
Alpha ID: alpha:person:dana-pizzuti-m-d-crnxVersion: public-0As of: 2026-09-29
- Executive
Key Claims
Biography
Board-certified physician with 30+ years pharmaceutical experience, previously SVP at Ascendis Pharma and led global regulatory affairs at Gilead Sciences managing over 500 people across 33 countries.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Executive career
- Current · dates not publishedChief Medical and Development Officer · Crinetics Pharmaceuticals, Inc.
- 2026 to end not publishedExecutive title: Chief Medical and Development Officer · Organization not publishedCRNX DEF 14A executive officers
Claims
Conflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
CRNX DEF 14A executive officers
sec filing · Source published: Apr 29, 2026 · Retrieved: May 16, 2026
Supports 5 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
- Executive company: Executive at Crinetics Pharmaceuticals, Inc. · Claim reviewed: May 16, 2026
- Executive title: Executive title: Chief Medical and Development Officer · Claim reviewed: May 16, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026
Open source
sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 6, 2026
Supports 1 claim
- Professional Role: Chief Medical and Development Officer at Crinetics Pharmaceuticals, Inc. · Claim reviewed: Sep 6, 2026
CRNX executive roster source
sec filing · Source published: Date unavailable · Retrieved: May 3, 2026
Supports 5 claims
- AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
- AI governance relevance: AI governance relevance reported from role and filings · Claim reviewed: May 3, 2026
- Executive company: Executive at Crinetics Pharmaceuticals, Inc. · Claim reviewed: May 16, 2026
- Executive function: Other Executive (OTHER_EXECUTIVE) · Claim reviewed: May 3, 2026
- Executive title: Executive title: Chief Medical and Development Officer · Claim reviewed: May 16, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
corroborated
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-09-29
- Biography
- published
- Board service
- not observed
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope

